期刊文献+

乳腺癌保乳手术切除范围的探讨 被引量:18

A study on adequate margine of mastectomy of breast cancer in breast-conserving surgery
原文传递
导出
摘要 目的探讨乳腺癌保乳手术的局部切除范围。方法回顾性分析南京医科大学第一附属医院乳腺外科、镇江市人民医院乳腺外科和常州市中医医院行保乳手术的275例连续病例,所有患者均按统一的手术步骤操作,并采用相同的术后辅助治疗,定期随访患者局部和全身情况。结果271例患者获得随访,随访率98.5%。随访时间1个月~9年9个月,中位随访34个月。2例局部复发,6例发生远处转移死亡。患者1年、3年、5年总生存率分别为99.5%、98.1%、95.7%。结论切除肿瘤周围1cm乳腺组织,冰冻切片证实边缘无肿瘤浸润,术后辅助化疗、内分泌治疗及放疗,手术是安全的,有益于提高患者生存质量。以钼靶片结合体检确定有无多中心、多灶性病变是安全、有效的。 Objective To study the scope of excison in breast-conserving surgery for breast carcinoma. Methods Clinical data of 275 breast cancer patients undergoing breast-conserving surgery in the First Affiliated Hospital of Nanjing Medical University, the Affiliated Zhenjiang Hospital of Jiangsu University and Changzhou Traditional Chinese Medicine Hospital were retrospectively analyzed. The operation procedure and postoperative adjuvant therapy were carried out with the same protocol. Local and general conditions of patients were followed up regularly. Results 271 out of 275 patients got follow-up. The follow-up rate was 98.5%. The follow-up time ranged from 1 month to 117 months, median follow-up time was 34 months. Six patients died of distant metastasis, 2 with local recurrence. The 1-year, 3-year, and 5-year overall survival rates were 99.5%, 98.1%, and 95.7% , respectively. Conclusions It is safe to excise 1 cm normal breast tissue with clear margin confirmed by frozen section, followed by postoperative adjuvant therapy, endocrine therapy, and radiotherapy, this improves the life quality of patients with breast cancer. It is safe and effective to determine whether the disease is multicentric or multifocal by mammogram plus clinical breast examination.
出处 《中华普通外科杂志》 CSCD 北大核心 2011年第10期833-836,共4页 Chinese Journal of General Surgery
关键词 乳腺肿瘤 外科手术 保乳手术 标本切缘 Breast neoplasms Surgical procedures, operative Breast-conserving surgery Surgical margin
  • 相关文献

参考文献9

  • 1NIH consensus conference. Treatment of early-stage breast cancer. JAMA, 1991,265:391-395.
  • 2Fisher B,Anderson S,Bryant J,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med,2002,347 : 1223-1241.
  • 3Veronesi U,Cascinelli N,Mariani L,et al. Twenty year follow-up of a randomized study comparing breast conserving surgery with radical mastectomy for early breast cancer. N Engl J Med,2002, 347 : 1227-1232.
  • 4张保宁,邵志敏,乔新民,李波,姜军,杨名添,王水,宋三泰,张斌,杨红健.中国乳腺癌保乳治疗的前瞻性多中心研究[J].中华肿瘤杂志,2005,27(11):680-684. 被引量:246
  • 5Hara Y, lwase H, Toyama T, et al. Telomerase activity levels for evaluating the surgical margin in breast-conserving surgery. Surg Today,2001,31:289-294.
  • 6Dillon MF, Hill AD, Quinn CM, et al. Pathologic assessment of adequate margin stastus in breast-conserving therapy. Ann Surg Oncol,2006,13 : 333-339.
  • 7Neuschatz AC, Dipetrillo T, Ssfaii H, et al. Long-term follow-up of a prospective policy of margin-directed radiation dose escalation in breast-conserving therapy. Cancer,2003,97:30-39.
  • 8Fisher B. Lumpectomy ( segmental mastectomy) and axillary dissection. In: Bland KI, Copeland EM (eds). The breast: Comprehensive management of benign and malignant diseases. Vol. 2,2th Edition,Saunders,Philadelphia. 1998:917-939.
  • 9Morrow M, Harris JR. More mastectomies:Is this what patients really want? J Clin Oncol,2009,27:4038-4040.

二级参考文献20

  • 1Bedwinek J. Treatment of stage I and Ⅱ adenocarcinoma of the breast by tumor excision and irradiation. Int J Radiat Oncol Biol Phys, 1981,7: 1553-1559.
  • 2Park CC, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol,2000, 18: 1668-1675.
  • 3Smitt MC, Nowels KW, Zdeblick MJ, et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer, 1995,76:259-267.
  • 4Bartelink H, Horiot JC, Poortmans P, et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med,2001,345:1378-1387.
  • 5National Institutes of Health. NIH consensus conference on the treatment of early-stage breast cancer. JAMA,1991,265:391-395.
  • 6Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med,2002,347: 1233-1241.
  • 7Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol,1999,17:2326-2333.
  • 8Renton SC, Gazet JC, Ford HT, et al. The importance of resection margin in conservative surgery for breast cancer. Eur J Surg Oncol,1996,22:17-22.
  • 9Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst,1996,88:1659-1664.
  • 10Forrest AP, Stewart HJ, Everington D, et al. Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet,1996,348:708-713.

共引文献245

同被引文献159

引证文献18

二级引证文献55

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部